SIOX
Sio Gene Therapies Inc.
Set alert
0.48 USD 0.00 0.00%
0.38 Day range 0.478
0.25 52-week range 0.50
- Open
- 0.38
- Prev close
- 0.478
- Mkt cap
- 0
- Vol
- 7.59K
- Avg vol
- 62.41K
- EPS
- -0.39
- P/E
- -1.23
- Div yield
- 0.00%
More statistics
- Low
- 0.38
- High
- 0.478
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 4, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
Financial health
Altman Z-Score
-17.26 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.7×
FY 2015 5y median -0.8× FY 2022
P/S 0.0×
FY 2015 5y median 0.0× FY 2022
P/B 0.8×
FY 2015 5y median 1.1× FY 2022
P/FCF -0.8×
FY 2015 5y median -0.9× FY 2022
EV/EBITDA 0.2×
FY 2015 5y median -0.2× FY 2022
EV/Sales 0.0×
FY 2015 5y median 0.0× FY 2022
FCF Yield -124.4%
FY 2015 5y median -111.9% FY 2022
Profitability
Gross Margin 0.0%
FY 2015 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2015 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2015 5y median 0.0% FY 2022
ROE -119.1%
FY 2015 5y median -119.1% FY 2022
ROIC -115.0%
FY 2015 5y median -115.0% FY 2022
ROA -95.7%
FY 2015 5y median -95.7% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2015 FY 2022
Operating Income -110.7%
FY 2015 FY 2022
EPS (diluted) -58.1%
FY 2015 FY 2022
Free Cash Flow -29.9%
FY 2015 FY 2022
Financial Health
Current Ratio 5.5×
FY 2015 5y median 3.4× FY 2022
Quick Ratio 5.5×
FY 2015 5y median 3.4× FY 2022
Debt / Equity 0.0×
FY 2015 5y median 0.3× FY 2022
Net Debt / EBITDA 0.9×
FY 2015 5y median 0.5× FY 2022
Interest Coverage -2677×
FY 2015 5y median -28.3× FY 2022
Dividends
Dividend Yield 0.0%
FY 2015 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2015 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-03-31